Northwest Biotherapeutics Statistics

Total Valuation

BST:NBYB has a market cap or net worth of EUR 312.66 million. The enterprise value is 386.49 million.

Market Cap	312.66M
Enterprise Value	386.49M

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.56B
Shares Outstanding	n/a
Shares Change (YoY)	+16.16%
Shares Change (QoQ)	+3.75%
Owned by Insiders (%)	2.36%
Owned by Institutions (%)	0.05%
Float	1.53B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	391.51
PB Ratio	-3.85
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.97
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.92

Financial Position

The company has a current ratio of 0.08

Current Ratio	0.08
Quick Ratio	0.05
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.51
Interest Coverage	-7.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-135.39%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	113.29%
Revenue Per Employee	31,944
Profits Per Employee	-3.11M
Employee Count	25
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.79%
50-Day Moving Average	0.21
200-Day Moving Average	0.22
Relative Strength Index (RSI)	40.34
Average Volume (20 Days)	15,820

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	17.04

Income Statement

In the last 12 months, BST:NBYB had revenue of EUR 798,605 and -77.75 million in losses. Loss per share was -0.06.

Revenue	798,605
Gross Profit	-27.97M
Operating Income	-55.32M
Pretax Income	-76.51M
Net Income	-77.75M
EBITDA	-53.81M
EBIT	-55.32M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 3.89 million in cash and 65.67 million in debt, giving a net cash position of -61.78 million.

Cash & Cash Equivalents	3.89M
Total Debt	65.67M
Net Cash	-61.78M
Net Cash Per Share	n/a
Equity (Book Value)	-81.18M
Book Value Per Share	-0.06
Working Capital	-68.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -42.77 million and capital expenditures -577,007, giving a free cash flow of -43.35 million.

Operating Cash Flow	-42.77M
Capital Expenditures	-577,007
Free Cash Flow	-43.35M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-6,927.32%
Pretax Margin	-9,580.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BST:NBYB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.16%
Shareholder Yield	-16.16%
Earnings Yield	-24.87%
FCF Yield	-13.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BST:NBYB has an Altman Z-Score of -77.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-77.21
Piotroski F-Score	1